Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS [Phase 3]

View source ↗

Summary

Phase 3 trial comparing trimetrexate plus leucovorin calcium rescue versus sulfamethoxazole-trimethoprim for Pneumocystis jirovecii pneumonia in AIDS patients h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucovorin Calcium Rescue (leucovorin calcium rescue)
  • Sulfamethoxazole-trimethoprim (sulfamethoxazole-trimethoprim)
  • Trimetrexate (trimetrexate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED